Pharma Business Development Operating System Parallel Trade | Compassionate Use | Emergency Supply
From Opportunistic Deals ³ Compliant, Repeatable Growth
Winning Aspiration Rapid, ethical access to critical medicines Regulatory excellence and compliance Protect pricing integrity and partner reputation
Where We Play Product Excess inventory, non-contracted, or emergency medicines Market Gov, hospitals, or accredited NGOs Pathway Compassionate use, EUA, or legal trade Pricing Zero reference price leakage, firewall maintained Counterparty Licensed entities, GDP compliance verified Repeatability Minimum 3-market expansion potential Need 4 of 6 criteria 4 or reject
How We Win Regulatory Speed We accelerate approval pathways, reducing typical approval times from months to weeks. Risk Absorption Partners supply products without reputational risk; we manage compliance, logistics, and execution.
Core Capabilities Regulatory Engineering Pathway design, submission, approval acceleration Supply Traceability & Serialization Product tracking, serialization, custody verification Pricing Firewall Design Market segmentation, price protection Institutional Access MOH relations, network, tender management Post-Deal Value Capture Market expansion, deal identification, partnership
Deal Governance 5 Mandatory Gates Ethical Need Patient need, urgency verified Regulatory Path Legal import route, timeline Economics Pricing, margin, payment secured Reputational Risk Partner exposure, media risk Scalability Expansion potential, repeatability Cross-functional review " CEO approval at Gate 4
Key Metrics Five Critical Metrics 14 Days
Offer ³ Patient Delivery Average time from offer acceptance to patient delivery. 73% Compassionate / Emergency Deals Total portfolio dedicated to urgent patient access programs. 2.8x Repeat Partner Ratio Average deals executed per pharmaceutical partner relationship. 0% Compliance Incidents Zero tolerance policy; immediate review for any violation. 82% Inventory Rescued Near-expiry inventory successfully deployed vs written off.
Outcome Fewer Deals Rigorous filtering, fewer opportunities Higher Trust Compliance excellence builds trust Scalable Impact Repeatable processes drive growth Disciplined filtering builds trust and enables scalable growth.